We are analyzing https://link.springer.com/article/10.1007/bf00194404.

Title:
Pharmacokinetics and absolute bioavailability of colchicine after i. v. and oral administration in healthy human volunteers and elderly subjects | European Journal of Clinical Pharmacology
Description:
The pharmacokinetics of colchicine were studied in six healthy male and four elderly female volunteers after i. v. and oral administration. Plasma samples were collected over 72 h and assayed for colchicine by a specific and sensitive radioimmunoassay. Plasma concentration-time curves were fitted using a three-compartmental model after i. v. administration of 0.5 mg (healthy volunteers) and 1 mg (elderly group) colchicine. The first distribution half-life (t1/2 λ1) was short: 9.2 min in healthy volunteers and 3.0 min in the elderly group; the second distribution half-life (t1/2 λ2) was of the same order for both groups, 1.2 h. Plasma elimination half-lives were also in the same range: 30 h for healthy volunteers versus 34 h for the elderly subjects. Mean residence time was also in the same range in the two groups: 27 h in healthy volunteers and 21 h for elderly subjects. The volume of distribution (Vz) was 6.71·kg-1 for the healthy group and 6.31·kg-1 for the elderly group, while Vss was smaller: 4.21·kg-1 for healthy volunteers and 2.91·kg-1 for elderly subjects. Total body clearance was 10.51·h-1 for healthy and 5.51·h-1 for elderly subjects. After oral administration of 1 mg, lag-time was 14 min in healthy volunteers and 11 min in elderly subjects. Maximal plasma concentration was 5.5 ng·ml-1 at 62 min in the healthy group, while in the elderly group Cmax was 12 ng·ml-1 at 87 min. Mean absolute bioavailability of the tablet was the same in both groups, 44% for healthy volunteers and 45% for elderly subjects.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Non-Profit & Charity
Health & Fitness
Dating & Relationships

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

colchicine, healthy, google, scholar, volunteers, elderly, subjects, article, pharmacokinetics, oral, scherrmann, administration, group, min, privacy, cookies, content, journal, bioavailability, girre, plasma, access, clin, pharmacol, information, publish, search, absolute, treatment, france, data, european, log, research, rochdi, sabouraud, radioimmunoassay, distribution, groups, open, discover, eur, pharmacokinet, download, hôpital, paris, springer, optional, personal, parties,

Topics {✒️}

month download article/chapter wagner-nelson absorption method plasma elimination half-lives plasma concentration-time curves long-term colchicine prophylaxis compartment open model article european journal privacy choices/manage cookies de kasep gi des intoxications aiguës full article pdf model-independent pharmacokinetics european economic area clinical pharmacology aims related subjects healthy human volunteers elderly female volunteers maximal plasma concentration healthy male volunteers scope submit manuscript total body clearance painful lumbosacral radiculopathy familial mediterranean fever long-term evaluation nguyen-hoang-nam hôpital fernand widal hôpital rené muret conditions privacy policy absolute bioavailability distribution half-life pharmacokinetics/bioavailability linear pharmacokinetic equations check access instant access journal finder publish accepting optional cookies elderly group cmax main content log scherrmann rights healthy volunteers elderly subjects article log privacy policy article cite personal data healthy male article rochdi books a scherrmann jm healthy group

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Pharmacokinetics and absolute bioavailability of colchicine after i. v. and oral administration in healthy human volunteers and elderly subjects
         description:The pharmacokinetics of colchicine were studied in six healthy male and four elderly female volunteers after i. v. and oral administration. Plasma samples were collected over 72 h and assayed for colchicine by a specific and sensitive radioimmunoassay. Plasma concentration-time curves were fitted using a three-compartmental model after i. v. administration of 0.5 mg (healthy volunteers) and 1 mg (elderly group) colchicine. The first distribution half-life (t1/2 λ1) was short: 9.2 min in healthy volunteers and 3.0 min in the elderly group; the second distribution half-life (t1/2 λ2) was of the same order for both groups, 1.2 h. Plasma elimination half-lives were also in the same range: 30 h for healthy volunteers versus 34 h for the elderly subjects. Mean residence time was also in the same range in the two groups: 27 h in healthy volunteers and 21 h for elderly subjects. The volume of distribution (Vz) was 6.71·kg-1 for the healthy group and 6.31·kg-1 for the elderly group, while Vss was smaller: 4.21·kg-1 for healthy volunteers and 2.91·kg-1 for elderly subjects. Total body clearance was 10.51·h-1 for healthy and 5.51·h-1 for elderly subjects. After oral administration of 1 mg, lag-time was 14 min in healthy volunteers and 11 min in elderly subjects. Maximal plasma concentration was 5.5 ng·ml-1 at 62 min in the healthy group, while in the elderly group Cmax was 12 ng·ml-1 at 87 min. Mean absolute bioavailability of the tablet was the same in both groups, 44% for healthy volunteers and 45% for elderly subjects.
         datePublished:
         dateModified:
         pageStart:351
         pageEnd:354
         sameAs:https://doi.org/10.1007/BF00194404
         keywords:
            Colchicine
            pharmacokinetics
            healthy volunteers
            elderly subjects
            absolute bioavailability
            Pharmacology/Toxicology
         image:
         isPartOf:
            name:European Journal of Clinical Pharmacology
            issn:
               1432-1041
               0031-6970
            volumeNumber:46
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:M. Rochdi
               affiliation:
                     name:Hôpital Fernand Widal
                     address:
                        name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A. Sabouraud
               affiliation:
                     name:Hôpital Fernand Widal
                     address:
                        name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C. Girre
               affiliation:
                     name:Hôpital Fernand Widal
                     address:
                        name:Unité de Pharmacologie Clinique, Hôpital Fernand Widal, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. Venet
               affiliation:
                     name:Hôpital René Muret
                     address:
                        name:Service de Gériatrie, Hôpital René Muret, Sevran, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. M. Scherrmann
               affiliation:
                     name:Hôpital Fernand Widal
                     address:
                        name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:Faculté des Sciences Pharmaceutiques et Biologiques
                     address:
                        name:Laboratoire de Pharmacie Clinique et Pharmacocinétique, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Pharmacokinetics and absolute bioavailability of colchicine after i. v. and oral administration in healthy human volunteers and elderly subjects
      description:The pharmacokinetics of colchicine were studied in six healthy male and four elderly female volunteers after i. v. and oral administration. Plasma samples were collected over 72 h and assayed for colchicine by a specific and sensitive radioimmunoassay. Plasma concentration-time curves were fitted using a three-compartmental model after i. v. administration of 0.5 mg (healthy volunteers) and 1 mg (elderly group) colchicine. The first distribution half-life (t1/2 λ1) was short: 9.2 min in healthy volunteers and 3.0 min in the elderly group; the second distribution half-life (t1/2 λ2) was of the same order for both groups, 1.2 h. Plasma elimination half-lives were also in the same range: 30 h for healthy volunteers versus 34 h for the elderly subjects. Mean residence time was also in the same range in the two groups: 27 h in healthy volunteers and 21 h for elderly subjects. The volume of distribution (Vz) was 6.71·kg-1 for the healthy group and 6.31·kg-1 for the elderly group, while Vss was smaller: 4.21·kg-1 for healthy volunteers and 2.91·kg-1 for elderly subjects. Total body clearance was 10.51·h-1 for healthy and 5.51·h-1 for elderly subjects. After oral administration of 1 mg, lag-time was 14 min in healthy volunteers and 11 min in elderly subjects. Maximal plasma concentration was 5.5 ng·ml-1 at 62 min in the healthy group, while in the elderly group Cmax was 12 ng·ml-1 at 87 min. Mean absolute bioavailability of the tablet was the same in both groups, 44% for healthy volunteers and 45% for elderly subjects.
      datePublished:
      dateModified:
      pageStart:351
      pageEnd:354
      sameAs:https://doi.org/10.1007/BF00194404
      keywords:
         Colchicine
         pharmacokinetics
         healthy volunteers
         elderly subjects
         absolute bioavailability
         Pharmacology/Toxicology
      image:
      isPartOf:
         name:European Journal of Clinical Pharmacology
         issn:
            1432-1041
            0031-6970
         volumeNumber:46
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:M. Rochdi
            affiliation:
                  name:Hôpital Fernand Widal
                  address:
                     name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A. Sabouraud
            affiliation:
                  name:Hôpital Fernand Widal
                  address:
                     name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C. Girre
            affiliation:
                  name:Hôpital Fernand Widal
                  address:
                     name:Unité de Pharmacologie Clinique, Hôpital Fernand Widal, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. Venet
            affiliation:
                  name:Hôpital René Muret
                  address:
                     name:Service de Gériatrie, Hôpital René Muret, Sevran, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. M. Scherrmann
            affiliation:
                  name:Hôpital Fernand Widal
                  address:
                     name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:Faculté des Sciences Pharmaceutiques et Biologiques
                  address:
                     name:Laboratoire de Pharmacie Clinique et Pharmacocinétique, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:European Journal of Clinical Pharmacology
      issn:
         1432-1041
         0031-6970
      volumeNumber:46
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Hôpital Fernand Widal
      address:
         name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
         type:PostalAddress
      name:Hôpital Fernand Widal
      address:
         name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
         type:PostalAddress
      name:Hôpital Fernand Widal
      address:
         name:Unité de Pharmacologie Clinique, Hôpital Fernand Widal, Paris, France
         type:PostalAddress
      name:Hôpital René Muret
      address:
         name:Service de Gériatrie, Hôpital René Muret, Sevran, France
         type:PostalAddress
      name:Hôpital Fernand Widal
      address:
         name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
         type:PostalAddress
      name:Faculté des Sciences Pharmaceutiques et Biologiques
      address:
         name:Laboratoire de Pharmacie Clinique et Pharmacocinétique, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:M. Rochdi
      affiliation:
            name:Hôpital Fernand Widal
            address:
               name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
               type:PostalAddress
            type:Organization
      name:A. Sabouraud
      affiliation:
            name:Hôpital Fernand Widal
            address:
               name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
               type:PostalAddress
            type:Organization
      name:C. Girre
      affiliation:
            name:Hôpital Fernand Widal
            address:
               name:Unité de Pharmacologie Clinique, Hôpital Fernand Widal, Paris, France
               type:PostalAddress
            type:Organization
      name:R. Venet
      affiliation:
            name:Hôpital René Muret
            address:
               name:Service de Gériatrie, Hôpital René Muret, Sevran, France
               type:PostalAddress
            type:Organization
      name:J. M. Scherrmann
      affiliation:
            name:Hôpital Fernand Widal
            address:
               name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
               type:PostalAddress
            type:Organization
            name:Faculté des Sciences Pharmaceutiques et Biologiques
            address:
               name:Laboratoire de Pharmacie Clinique et Pharmacocinétique, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
      name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
      name:Unité de Pharmacologie Clinique, Hôpital Fernand Widal, Paris, France
      name:Service de Gériatrie, Hôpital René Muret, Sevran, France
      name:Institut National de la Santé et de la Recherche Médicale, Hôpital Fernand Widal, Paris, France
      name:Laboratoire de Pharmacie Clinique et Pharmacocinétique, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(52)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.06s.

LINK . SPRINGER . COM {}